Community Based Strategies for Early Detection of Melanoma
A Pilot Feasibility Study of Community Based Strategies for Early Detection of Melanoma
1 other identifier
observational
200
0 countries
N/A
Brief Summary
The purpose of this study is to pilot the use of community education and digital dermatology to increase the early detection of curable melanomas.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 9, 2021
CompletedFirst Posted
Study publicly available on registry
March 16, 2021
CompletedStudy Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedAugust 29, 2023
August 1, 2023
1.1 years
March 9, 2021
August 28, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Completion of self and partner skin examinations
Proportion of individuals recruited to those that follow through with the protocol
3 months
Completion of self and partner skin examinations
Proportion of individuals recruited to those that follow through with the protocol
6 months
Interventions
The main procedures of this study include educational sessions about melanoma and how to detect it at its earliest stages with the help of a community health worker, conducting a self-skin examination every three months, helping to perform a skin examination every three months for a family member or friend who would be selected as a "partner", and completing short questionnaires at the beginning of the study, at month three during the study, and at completion of the study.
Eligibility Criteria
200 melanoma survivors drawn from the California Cancer Registry will be invited to participate in the study. Assuming a 20% response rate, approximately 40 individuals will be identified to participate in the study, including 20 in Southern California and 20 in Northern California. Participants will be invited to identify up to four friends or first-degree family members to also participate in the study, for a total of 200 participants.
You may qualify if:
- years and older
- \>1mm lesion thickness with ulceration (T2b) or \>2mm lesion thickness (T3/T4)
- Low socioeconomic status (SES) Non-Latinx White individuals (according to Yost's index SES level based on a principal components analysis)
- Latinx individuals
- Individual resides in semi-rural area, including zip codes within Antelope Valley in Southern California and Salinas in Northern California
- Individual speaks and reads English or Spanish
- Voluntary willingness and comprehension to consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cedars-Sinai Medical Centerlead
- Stanford Universitycollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Haile, DrPH, MPH
Cedars-Sinai
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Cancer Research Center for Health Equity
Study Record Dates
First Submitted
March 9, 2021
First Posted
March 16, 2021
Study Start
January 1, 2024
Primary Completion
January 31, 2025
Study Completion
March 1, 2025
Last Updated
August 29, 2023
Record last verified: 2023-08